⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001817449

Stagliano Nancy

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

Transactions

11

Companies

2

Filings

3

CIK

0001817449

Forms 4 and 5

Insider transactions

11 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-21	ETRAElectra Therapeutics, Inc.C Conversion	Director	CConversion	+256K sh	—	—	255,635
2026-09-21	ETRAElectra Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion	Director	CConversion	−256K sh	—	—	0
2021-04-01	Pandion Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−1,000 sh	$60.00	−$60K	0
2021-04-01	Pandion Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−73.1K sh	$60.00	−$4.38M	0
2021-04-01	Pandion Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.7K sh	—	—	0
2020-07-21	Pandion Therapeutics, Inc.C Conversion	Director	CConversion	+15K sh	—	—	73,067
2020-07-21	Pandion Therapeutics, Inc.P Purchase	Director	PPurchase	+1,000 sh	$18.00	+$18K	1,000
2020-07-21	Pandion Therapeutics, Inc.Series A Preferred StockC Conversion	Director	CConversion	−28.6K sh	—	—	0
2020-07-21	Pandion Therapeutics, Inc.Series B Preferred StockC Conversion	Director	CConversion	−47.9K sh	—	—	0
2020-07-17	Pandion Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+3,674 sh	—	—	3,674
2020-07-17	Pandion Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	13,997

Recent filings

3

Accepted (ET)
Sep 214
Stagliano Nancy0001817449-26-000009
SEC(opens sec.gov)
Apr 14
Stagliano Nancy0000899243-21-014447
SEC(opens sec.gov)
Jul 214
Stagliano Nancy0000899243-20-019863
SEC(opens sec.gov)

Companies

2

Address

C/O ELECTRA THERAPEUTICS, INC. 230 E GRAND AVENUE, SUITE S-100

SOUTH SAN FRANCISCO, CA, 94080